Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Celldex Therapeutics sell Barclays PLC

Celldex Therapeutics
Start price
€21.80
17.12.25 / 50%
Target price
€20.43
17.12.26
Performance (%)
6.42%
Price
€23.60
09.01.26
Summary
This prediction is currently active. With a performance of 6.42%, the SELL prediction by Barclays_PLC for Celldex Therapeutics is trending in the wrong direction This prediction currently runs until 17.12.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this prediction
Performance without dividends (%)
Name 1w
Celldex Therapeutics 3.509%
iShares Core DAX® 3.002%
iShares Nasdaq 100 2.966%
iShares Nikkei 225® 5.606%
iShares S&P 500 2.312%

Comments by Barclays_PLC for this prediction

In the thread Celldex Therapeutics diskutieren
Prediction Sell
Perf. (%) 6.42%
Target price 20.431
Change
Ends at 17.12.26

Celldex Therapeutics (NASDAQ:CLDX) had its price target raised by analysts at Barclays PLC from $21.00 to $24.00. They now have an "underweight" rating on the stock.
Ratings data for CLDX provided by MarketBeat

Barclays PLC 
0
Report Share
17.12.25

Stopped prediction by Barclays_PLC for Celldex Therapeutics

sell
Celldex Therapeutics

Start price
Target price
Perf. (%)
€20.80
11.11.25
€18.18
11.11.26
11.54%
09.01.26

Barclays PLC 
11.11.25 50%
sell
Celldex Therapeutics

Start price
Target price
Perf. (%)
€23.20
13.10.25
€21.52
13.10.26
1.72%
09.01.26

Barclays PLC 
13.10.25 50%